Angiogenesis and invasion in glioma

被引:220
作者
Onishi, Manabu [1 ]
Ichikawa, Tomotsugu [1 ]
Kurozumi, Kazuhiko [1 ]
Date, Isao [1 ]
机构
[1] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan
关键词
Glioma; Invasion; Angiogenesis; Hypoxia; Molecular targeted therapy; PHASE-II TRIAL; ENDOTHELIAL GROWTH-FACTOR; RECURRENT MALIGNANT GLIOMAS; HYPOXIA-INDUCIBLE FACTOR-1; ASPARTIC ACID PEPTIDE; GELATINASE-B MMP-9; CANCER-CELL-LINES; GLIOBLASTOMA-MULTIFORME; BRAIN-TUMORS; IN-VITRO;
D O I
10.1007/s10014-010-0007-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite advances in surgical and medical therapy, glioblastoma consistently remains a fatal disease. Over the last 20 years, no significant increase in survival has been achieved for patients with this disease. The formation of abnormal tumor vasculature and glioma cell invasion along white matter tracts are believed to be the major factors responsible for the resistance of these tumors to treatment. Therefore, investigation of angiogenesis and invasion in glioblastoma is essential for the development of a curative therapy. In our report, we first reviewed certain histopathological studies that focus on angiogenesis and invasion of human malignant gliomas. Second, we considered several animal models of glioma available for studying angiogenesis and invasion, including our novel animal models. Third, we focused on the molecular aspects of glioma angiogenesis and invasion, and the key mediators of these processes. Finally, we discussed the recent and ongoing clinical trials targeting tumor angiogenesis and invasion in glioma patients. A better understanding of the mechanism of glioma angiogenesis and invasion will lead to the development of new treatment methods.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 115 条
  • [1] RETRACTED: Down-regulation of integrin αvβ3 expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes (Retracted article. See vol. 295, pg. 13134, 2020)
    Adachi, Y
    Lakka, SS
    Chandrasekar, N
    Yanamandra, N
    Gondi, CS
    Mohanam, S
    Dinh, DH
    Olivero, WC
    Gujrati, M
    Tamiya, T
    Ohmoto, T
    Kouraklis, G
    Aggarwal, B
    Rao, JS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) : 47171 - 47177
  • [2] Sorafenib (BAY 43-9006, Nexavar®), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature
    Adnane, Lila
    Trail, Pamela A.
    Taylor, Ian
    Wilhelm, Scott M.
    [J]. REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 : 597 - +
  • [3] Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
    Baker, AH
    George, SJ
    Zaltsman, AB
    Murphy, G
    Newby, AC
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1347 - 1355
  • [4] The role of myosin II in glioma invasion of the brain
    Beadle, Christopher
    Assanah, Marcela C.
    Monzo, Pascale
    Vallee, Richard
    Rosenfeld, Steven S.
    Canoll, Peter
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2008, 19 (08) : 3357 - 3368
  • [5] Bello L, 2004, CANC TREAT, V117, P263
  • [6] The role of pericytes in blood-vessel formation and maintenance
    Bergers, G
    Song, S
    [J]. NEURO-ONCOLOGY, 2005, 7 (04) : 452 - 464
  • [7] Modes of resistance to anti-angiogenic therapy
    Bergers, Gabriele
    Hanahan, Douglas
    [J]. NATURE REVIEWS CANCER, 2008, 8 (08) : 592 - 603
  • [8] PHASE-I STUDIES OF TREATMENT OF MALIGNANT GLIOMAS AND NEOPLASTIC MENINGITIS WITH I-131 RADIOLABELED MONOCLONAL-ANTIBODIES ANTI-TENASCIN 81C6 AND ANTI-CHONDROITIN PROTEOGLYCAN SULFATE ME1-14 F(AB')(2) - A PRELIMINARY-REPORT
    BIGNER, DD
    BROWN, M
    COLEMAN, RE
    FRIEDMAN, AH
    FRIEDMAN, HS
    MCLENDON, RE
    BIGNER, SH
    ZHAO, XG
    WIKSTRAND, CJ
    PEGRAM, CN
    KERBY, T
    ZALUTSKY, MR
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1995, 24 (01) : 109 - 122
  • [9] MSAP enhances migration of C6 glioma cells through phosphorylation of the myosin regulatory light chain
    Bornhauser, BC
    Lindholm, D
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (11) : 1260 - 1266
  • [10] Hypoxia:: the tumor's gateway to progression along the angiogenic pathway
    Brahimi-Horn, C
    Berra, E
    Pouysségur, J
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (11) : S32 - S36